Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 50% on Thursday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares were traded during trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Stock Performance
The stock has a 50 day moving average price of C$0.07 and a two-hundred day moving average price of C$0.06. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The company has a market capitalization of C$14.64 million, a price-to-earnings ratio of -10.50 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Choose Top Rated Stocks
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- ESG Stocks, What Investors Should Know
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
- Stock Splits, Do They Really Impact Investors?
- Rebalancing in 2025: Here Are 3 Stocks to Buy Under $10
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
